Clinical Trials Arena on MSN
Bausch Health’s new formulation of Xifaxan fails pair of Phase III trials
Rifaximin SSD failed to significantly delay the onset of HE in patients with liver cirrhosis, but Bausch is yet to scrap the ...
Nov. 2, 2005 (Honolulu) — Several gastrointestinal disorders beyond traveler's diarrhea respond to rifaximin (Xifaxan), according to investigators who presented their findings here at the 70th annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results